SkinBioTherapeutics PLC (SBTX)

London

Currency in GBP

Disclaimer

10.73

-0.52(-4.62%)

Real-time Data09:33:20

Fair Value

Day's Range

10.73

11.20

52 wk Range

7.00

29.50

SkinBioTherapeutics (SBTX) Income Statement & Profits

Assess the SkinBioTherapeutics Income Statement (earnings report), showing the company's financial performance from operating and non operating activities such as revenue, expenses and income. Check assets and liabilities, diluted earnings per share (EPS), and net income after taxes for the last 4 periods (either quarterly or annually).

Investors who need greater depth or who want to customise how data is presented to fit their own investment styles are able to do so via their very own InvestingPro account.

Advanced Income Statement

Period Ending:

2016

30/06

2017

30/06

2018

30/06

2019

30/06

2020

30/06

2021

30/06

2022

30/06

2023

30/06

Total Revenues

-

0.07

0.13

Total Revenues Growth

-

-

+76.64%

Cost Of Revenues

-

0.03

0.05

Gross Profit

-

0.05

0.09

Gross Profit Growth

-

-

+87.9%

Gross Profit Margin %

-

60.64%

64.51%

Other Operating Expenses, Total

1.5

3.03

3.08

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-7.59%	+102.22%	+1.89%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.51	0.86	0.93
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.99	2.17	2.15
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-

Operating Income

-1.5

-2.98

-3

Operating Income Growth

+7.59%

-99.19%

-0.58%

EBIT Margin %

-

-3,988.83%

-2,271.26%

Net Interest Expenses

-0

-0.01

-0.01

Net Interest Expenses Growth

-

-994.49%

+12.32%

Interest Expense, Total

-0

-0.01

-0.01

Interest And Investment Income

-

-

-

Other Non Operating Expenses, Total

-

-

-

EBT, Excl. Unusual Items

-1.5

-2.99

-3.01

Gain (Loss) On Sale Of Assets

-

-

-

Other Unusual Items, Total

-

-

-

EBT, Incl. Unusual Items

-1.5

-2.99

-3.01

EBT, Incl. Unusual Items Growth

+7.53%

-99.74%

-0.54%

EBT, Incl. Unusual Items Margin

-

-4,002.38%

-2,277.98%

Income Tax Expense

-0.07

-0.2

-0.17

Net Income to Company

-1.43

-2.79

-2.84

Minority Interest

-

-

-

Net Income

-1.43

-2.79

-2.84

Net Income Growth

+4.47%

-94.88%

-1.52%

Net Income Margin %

-

-3,735.37%

-2,146.91%

Preferred Dividend and Other Adjustments

-

-

-

Net Income to Common Excl. Extra Items

-1.43

-2.79

-2.84

Basic EPS - Continuing Operations

-0.01

-0.02

-0.02

Basic EPS - Continuing Operations Growth

+16.59%

-82.35%

+3.37%

Diluted EPS - Continuing Operations

-0.01

-0.02

-0.02

Diluted EPS - Continuing Operations Growth

+16.59%

-82.35%

+3.37%

Basic Weighted Average Shares Outstanding

146.7

156.78

164.71

Diluted Weighted Average Shares Outstanding

146.7

156.78

164.71

Dividend Per Share

-

-

-

Dividend Per Share Growth

-

-

-

EBITDA

-1.5

-2.98

-2.99

EBITDA Growth

+7.4%

-99.4%

-0.19%

EBITDA Margin %

-

-3,988.49%

-2,262.33%

EBIT

-1.5

-2.98

-3

* In Millions of GBP (except for per share items)